Cite
HARVARD Citation
Zaja, F. et al. (2018). Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. Leukemia & lymphoma. 59 (12), pp. 2904-2910. [Online].